Drug · DIN 02557010
IQIRVO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 20, 2025; first marketed May 20, 2025.
- Drug Identification Number (DIN)
- 02557010
- Company (DIN owner)
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Elafibranor A05AX06
- Class
- Human
- Record last updated
- October 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELAFIBRANOR | 80 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 25, 2025: NOC 35246New Drug Submission (NDS)